By combining the right data with the right models, social determinants of health are a powerful asset in predictive models of health, outcomes, and potential health disparities, according to researchers from Mayo Clinic Platform and Change Healthcare.
It’s not enough to provide evidence that AI tools are clinically effective; practitioners want reasonable explanations demonstrating that “they will do what they claim to do,” according to Dr. John Halamka and Paul Cerrato of Mayo Clinic Platform.
The most sophisticated algorithms for screening diseases and improving treatments won’t do much good if they misrepresent the populations they seek to serve, according to Paul Cerrato and Dr. John Halamka. In this blog, they discuss the “ethical dilemma” that can deter digital health initiatives.
One way to help drive adoption of AI tools? Creating “a set of standards to help clinicians and other decision makers separate useful tools from junk science,” according to John Halamka, MD, and Paul Cerrato of Mayo Clinic Platform.
Although tech-focused organizations have traditionally relied on a pipeline approach to driving innovation, data suggest that a platform approach may be more effective, particularly when it comes to patient care, according to Dr. John Halamka and Paul Cerrato.